Built by clinicians and entrepreneurs who understand both the science and the commercial challenge.
SHAARPEC brings together Harvard Medical School faculty, multi-exit health tech entrepreneurs, and deep healthcare finance expertise — united around a single mission: giving pharma commercial teams earlier, more accurate intelligence.
LEADERSHIP
The people building SHAARPEC
Tom Arneman
Chief Executive Officer
Multi-exit digital health entrepreneur and Entrepreneur in Residence at the Mass General Brigham digital innovation team. Tom leads company strategy, business development, and investor relations.
Philip Anderson, MD
Chief Medical Officer
Emergency medicine physician and Assistant Professor at Harvard Medical School, with a clinical appointment at Mass General Brigham. Philip leads scientific strategy, client engagement, and the design of SHAARPEC’s trajectory-based analytics platform.
Thomas Davidsson
Chief Operating Officer
Swedish digital health entrepreneur with a background in finance and economics. Thomas oversees operations, international expansion, and the company’s strategic partnerships across the EU and US markets.
Sal Renzo
Chief Business Officer
Healthcare finance, strategy, and M&A leader with deep private equity experience. Sal drives SHAARPEC’s commercial growth strategy, investor engagement, and financial operations.
Farzaneh Etminani, PhD
Lead Data Scientist
PhD researcher and faculty member at Halmstad University with expertise in AI, machine learning, and predictive modeling applied to healthcare data. Farzaneh is the intellectual architect of SHAARPEC’s trajectory modeling methodology.